T3 Pharma retweeted
#NEWS: We are acquiring T3 Pharmaceuticals aiming to cure cancers and transform lives through science. Learn more about how we will realize the full potential of this novel cancer therapy platform: bit.ly/47BJHjm
#ResearchCollaboration #ImmunoOncology #Cancer
Happy to share that we have received funding by the Swiss Accelerator. We are honored and extremely proud to be among these highly innovative companies! Thank you @Innosuisse for trusting in T3 Pharma's team and our bacterial cancer therapy platform.
innosuisse.ch/inno/en/home/m…
T3 Pharma has been awarded the SEF award 2021 in the category High-tech/Biotech!!! We are extremely proud to have been selected by the jury for such prestigious price. #SEF21 #SEFaward21
T3 Pharma in the final of the Swiss Economic Award 2021! We are proud to be able to pitch at the Swiss Economic Forum on 1/2 September in Interlaken and ultimately hope for first place.
More at swisseconomic.ch/en/swiss-ec… #SEFAward21 #SEF21
Today we raised a 25M CHF #FinancingRound from existing investors: @Boehringer Ingelheim Venture Fund, #ReferenceCapital SA, #Wille Finance AG and private investors. This will support #ClinicalTrials for our lead candidate, T3P-Y058-739, to treat #SolidTumors.






